American Society of Hematology

Committee on Government Affairs

Committee Roster

Alan Glen Rosmarin, MD ('20)

Vice Chair
Jennifer Holter Chakrabarty, MD ('20)

Appointed Members
Michael R. Bishop, MD ('22)
Rachel Cook, MD ('20)
Kevin J. Curran, MD ('19)
Mary C. Dinauer, MD,PhD ('22)
Laura E. Finn, MD ('19)
Jonathan Hoggatt, PhD ('20)
Ray J. Hohl, MD, PhD ('20)
Sarah A. Holstein, MD,PhD ('19)
Dianna S. Howard, MD ('21)
Julie Kanter, MD ('22)
Neil E. Kay, MD ('21)
Sophie Lanzkron, MD ('21)
Brea C. Lipe, MD ('19)
Troy C. Lund, MD,MS,PhD ('20)
Heather Male, MD ('19)
Emily Meier, MD ('21)
Alice S. Mims, MD ('22)
Lori S. Muffly, MD ('22)
Aziz Nazha, MD ('22)
David A. Rizzieri, MD ('22)
Bart Lee Scott, MD ('21)
Kim Smith-Whitley, MD ('21)

Ex Officio Members
Stephanie J. Lee, MD, MPH ('20) - President-Elect
Roy L. Silverstein, MD ('19) - President
Martin S. Tallman, MD ('21) - Vice President

Joseph C. Alvarnas, MD ('19) - Chair, Committee on Practice
Selina Luger, MD, FRCPC ('20) - Member, Committee on Scientific Affairs

Staff Liaison
Suzanne Leous, MPA

Committee Mandate

The Committee on Government Affairs, with appropriate counsel and approval by the Executive Committee, leads the Society’s efforts before Congress and the Executive branch on the research and science issues important to hematology. In concert with the Committee on Practice, the Committee on Government Affairs represents the interests of hematology researchers and practitioners on Capitol Hill and in the Executive branch agencies concerned with the study and treatment of blood and blood-related diseases.

The Committee on Government Affairs is kept abreast of government affairs issues related to hematology research and practice by staff. When Executive branch or Congressional actions are likely to have an impact on our field, the Committee formulates an action plan consistent with ASH policy to represent the interests of the Society's members. In addition, when opportunities for new initiatives arise, the Committee pursues them with Executive branch and Congressional policymakers.

The issues to be addressed by the Committee on Government Affairs are mostly those related to hematology research, including funding for the National Institutes of Health (NIH), although the Committee also works with the Committee on Practice to incorporate into its agenda hematology reimbursement issues and other challenges facing the practicing hematologist. In addition, the Committee on Government Affairs communicates and coordinates government affairs activities with appropriate public, patient, and professional organizations. The Committee also interacts closely with the Committee on Communications, Publications Committee, and Committee on Training to collaborate on projects.

The Committee on Government Affairs structure includes the Chair of the Committee on Practice, a member of the Committee on Scientific Affairs, and the Chair of the ASH Advocacy Leadership Institute as liaison members.

Members of the Committee on Government Affairs are expected to attend committee meetings, including a two-day meeting involving Capitol Hill visits in the spring and other occasional meetings with members of Congress as well as NIH or other federal agencies as needed throughout the year. Committee members are expected to participate in the ASH Grassroots Network (including any event held during the ASH annual meeting), occasional conference calls, and the development of policy statements, comment letters, and other related documents.

The Chair of the Committee on Government Affairs serves as a liaison member of the Committee on Practice and is expected to attend the meetings of that committee. A member of the Committee on Government Affairs serves as a liaison member of the Committee on Communications and is expected to attend the meetings of that committee.

back to top